Search Result "osteosarcoma tumorigenesis"
RUNX2 and Osteosarcoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 7 Year: 2015 Page: 881-887
Author(s): Na Li,Dongwei Luo,Xiaoxia Hu,Wei Luo,Guanghua Lei,Qian Wang,Ting Zhu,Junxia Gu,Yaojuan Lu,Qiping Zheng
Targeting Signaling Pathway by Curcumin in Osteosarcoma
Journal: Current Molecular Pharmacology
Volume: 16 Issue: 1 Year: 2023 Page: 71-82
Author(s): Parnia Rahnamay Farnood,Romina Danesh Pazhooh
Biomarkers and Osteosarcoma and IGF
Journal: Recent Patents on Biomarkers
Volume: 3 Issue: 3 Year: 2013 Page: 188-195
Author(s): Simmi Kharb
The Retinoblastoma Protein in Osteoblast Differentiation and Osteosarcoma
Journal: Current Molecular Medicine
Volume: 6 Issue: 7 Year: 2006 Page: 809-817
Author(s): Amit Deshpande, Philip W. Hinds
Integral Composite of Malignant Transformation and Metastatic Potentiality in Osteosarcoma
Ebook: Theory in the Pathophysiology of Carcinogenesis
Volume: 1 Year: 2011
Author(s): Lawrence M. Agius
Doi: 10.2174/978160805266011101010028
circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 4 Year: 2020 Page: 288-294
Author(s): Xinyu Tan,Duxun Tan,Haomiao Li,Ye Lin,Zhishen Wen,Canjun Zeng
Targeting BMP9-Promoted Human Osteosarcoma Growth by Inactivation of Notch Signaling
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 3 Year: 2014 Page: 274-285
Author(s): Ruidong Li,Wenwen Zhang,Jing Cui,Wei Shui,Liangjun Yin,Yang Wang,Hongyu Zhang,Ning Wang,Ningning Wu,Guoxin Nan,Xian Chen,Sheng Wen,Fang Deng,Hongmei Zhang,Guolin Zhou,Zhan Liao,Junhui Zhang,Qian Zhang,Zhengjian Yan,Wei Liu,Zhonglin Zhang,Jixing Ye,Youlin Deng,Hue H. Luu,Rex C. Haydon,Tong-Chuan He,Zhong-Liang Deng
Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 4830-4834
Author(s): Li Cheng, Chongchong Wang, Juehua Jing
Silencing FUT4 Inhibits the Progression of Osteosarcoma through Activation ofFOXO1
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 6 Year: 2024 Page: 440-447
Author(s):
MiR-134, Mediated by IRF1, Suppresses Tumorigenesis and Progression by Targeting VEGFA and MYCN in Osteosarcoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 10 Year: 2020 Page: 1197-1208
Author(s): Zhuo Ma,Kai Li,Peng Chen,Qizheng Pan,Xuyang Li,Guoqing Zhao